Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease

[1]  C. Lang,et al.  Measurement of coronary vasomotor function: getting to the heart of the matter in cardiovascular research. , 2004, Clinical science.

[2]  T. Lehtimäki,et al.  Endothelial Dysfunction and Increased Arterial Intima-Media Thickness in Children With Type 1 Diabetes , 2004, Circulation.

[3]  Y. Yoshimasa,et al.  Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension. , 2004, American journal of hypertension.

[4]  O. Raitakari,et al.  Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. , 2004, The American journal of cardiology.

[5]  B. Stemper,et al.  Postischemic cutaneous hyperperfusion in the presence of forearm hypoperfusion suggests sympathetic vasomotor dysfunction in Fabry disease , 2003, Journal of Neurology.

[6]  B. Wożakowska-Kapłon.  [Cardiac manifestations of Fabry disease]. , 2003, Polskie Archiwum Medycyny Wewnetrznej.

[7]  A. Linhart,et al.  Cardiac involvement in Fabry disease , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[8]  P. Boutouyrie,et al.  Arterial remodelling in Fabry disease , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[9]  H. Mabuchi,et al.  Carotid artery intima‐media thickness and brachial artery flow‐mediated vasodilation in asymptomatic Japanese male subjects amongst apolipoprotein E phenotypes , 2002, Journal of internal medicine.

[10]  D. Neglia,et al.  Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.

[11]  R. Schiffmann,et al.  Arterial wall properties and Womersley flow in Fabry disease. , 2002 .

[12]  M. Mulvany,et al.  Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia , 2001, Circulation.

[13]  K. Macdermot,et al.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males , 2001, Journal of medical genetics.

[14]  K. Macdermot,et al.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females , 2001, Journal of medical genetics.

[15]  M. Gladwin,et al.  Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry Disease: Reversal by Enzyme Replacement Therapy , 2001, Circulation.

[16]  P. Boutouyrie,et al.  Non-invasive evaluation of arterial involvement in patients affected with Fabry disease , 2001, Journal of medical genetics.

[17]  R. Schiffmann,et al.  Selective Arterial Distribution of Cerebral Hyperperfusion in Fabry Disease , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[18]  R. Schiffmann,et al.  Enhanced Endothelium-Dependent Vasodilation in Fabry Disease , 2001, Stroke.

[19]  O. Rimoldi,et al.  Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. , 2001, Cardiovascular research.

[20]  N. Buus,et al.  Peripheral Flow Response to Transient Arterial Forearm Occlusion Does Not Reflect Myocardial Perfusion Reserve , 2001, Circulation.

[21]  J. Czernin,et al.  Altered Regulation of the Myocardial Microcirculation in Young Smokers , 2001, Cardiology.

[22]  O. Raitakari,et al.  Noninvasive assessment of brachial artery endothelial function with digital ultrasound and 13-MHz scanning frequency: feasibility of measuring the true inner luminal diameter using the intima-lumen interface. , 2000, Ultrasound in medicine & biology.

[23]  T. Lüscher,et al.  Coronary Heart Disease in Smokers: Vitamin C Restores Coronary Microcirculatory Function , 2000, Circulation.

[24]  M. Aschermann,et al.  New insights in cardiac structural changes in patients with Fabry's disease. , 2000, American heart journal.

[25]  J. Viikari,et al.  Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. , 1999, Atherosclerosis.

[26]  J. Viikari,et al.  Coronary flow reserve in young men with familial combined hyperlipidemia. , 1999, Circulation.

[27]  M. Phelps,et al.  Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. , 1998, Circulation.

[28]  J. Viikari,et al.  Early impairment of coronary flow reserve in young men with borderline hypertension. , 1998, Journal of the American College of Cardiology.

[29]  T. Lehtimäki,et al.  Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.

[30]  M. Omata,et al.  Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. , 1997, Journal of the American College of Cardiology.

[31]  U. Ruotsalainen,et al.  Using local median as the location of the prior distribution in iterative emission tomography image reconstruction , 1997, 1997 IEEE Nuclear Science Symposium Conference Record.

[32]  P. Nihoyannopoulos,et al.  Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. , 1997, European heart journal.

[33]  M. Omata,et al.  Reduced coronary flow reserve in familial hypercholesterolemia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  J. Viikari,et al.  Coronary flow reserve is impaired in young men with familial hypercholesterolemia. , 1996, Journal of the American College of Cardiology.

[35]  S. Levine,et al.  Cerebrovascular complications of Fabry's disease , 1996, Annals of neurology.

[36]  M. Phelps,et al.  Effect of acute and long-term smoking on myocardial blood flow and flow reserve. , 1995, Circulation.

[37]  A. Lammertsma,et al.  Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  O Muzik,et al.  Early Detection of Abnormal Coronary Flow Reserve in Asymptomatic Men at High Risk for Coronary Artery Disease Using Positron Emission Tomography , 1994, Circulation.

[39]  J. Ménard,et al.  Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. , 1993, BMJ.

[40]  D. Celermajer,et al.  Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.

[41]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[42]  A. Lammertsma,et al.  Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  A. L'Abbate,et al.  Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. , 1991, Journal of the American College of Cardiology.

[44]  R. Tomanek.  Response of the coronary vasculature to myocardial hypertrophy. , 1990, Journal of the American College of Cardiology.

[45]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[46]  A. Nitenberg,et al.  Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. , 1985, The American journal of cardiology.

[47]  K. Sheth,et al.  Electrocardiograms in Fabry's disease. , 1982, Journal of electrocardiology.

[48]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[49]  C. Rackley,et al.  Measurement of Left Ventricular Wall Thickness and Mass by Echocardiography , 1972, Circulation.

[50]  R. Brady,et al.  Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. , 1967, The New England journal of medicine.